|
CDC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.16680056914265E-13 |
| Normal-vs-Stage2 |
1.309780E-02 |
| Normal-vs-Stage3 |
2.04270000003781E-06 |
| Normal-vs-Stage4 |
2.185700E-02 |
| Stage1-vs-Stage2 |
5.420400E-01 |
| Stage1-vs-Stage3 |
1.158930E-03 |
| Stage1-vs-Stage4 |
9.358100E-02 |
| Stage2-vs-Stage3 |
3.715600E-02 |
| Stage2-vs-Stage4 |
1.614420E-01 |
| Stage3-vs-Stage4 |
7.393600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.3339000004553E-07 |
| Normal-vs-Asian |
8.782200E-02 |
| Caucasian-vs-AfricanAmerican |
4.903400E-01 |
| Caucasian-vs-Asian |
1.602750E-01 |
| AfricanAmerican-vs-Asian |
3.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.01859998213882E-09 |
| Male-vs-Female |
2.655100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.34559999999973E-05 |
| Normal-vs-Extreme_Weight |
4.44410064304179E-11 |
| Normal-vs-Obese |
1.68350000051554E-07 |
| Normal-vs-Extreme_Obese |
5.303400E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.649600E-02 |
| Normal_Weight-vs-Obese |
7.612200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.763300E-03 |
| Extreme_Weight-vs-Obese |
8.144500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.897800E-02 |
| Obese-vs-Extreme_Obese |
3.121100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.737600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.59792187762287E-14 |
| Normal-vs-Age(61-80Yrs) |
1.31159527683167E-11 |
| Normal-vs-Age(81-100Yrs) |
1.119630E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.163700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.090100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.468130E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.841600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.444600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.407810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.25140000029056E-07 |
| Normal-VS-KIRP CIMP |
4.213800E-04 |
| Normal-VS-Unclassified PRCC |
3.44549999975463E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.714420E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.418260E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.482570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.81459999998501E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.236400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.338500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79949999995688E-06 |
| Normal-vs-N1 |
1.74705999999025E-05 |
| Normal-vs-N2 |
1.208240E-01 |
| N0-vs-N1 |
1.804720E-03 |
| N0-vs-N2 |
1.190620E-01 |
| N1-vs-N2 |
5.701000E-01 |
|
|
